Personalised Medicines
EBE addresses issues around personalised medicines
EBE Task Force on Personalised Medicines launched in 2010 has been created to identify and fill in gaps in knowledge to facilitate common European industry positioning on issues related to personalised medicines. The Task Force will also work with European stakeholders to shape a favourable policy environment for the full realization of personalised medicine, encouraging the co-development of drugs and diagnosis. The Task Force currently combines business, policy and regulatory expertise provided by a diverse group of member companies active in personalised medicines